B. Riley upgraded Madrigal Pharmaceuticals (MDGL) to Buy from Neutral with a price target of $422, up from $236. The firm notes the erosion of three key pillars to the prior cautious outlook ...

B. Riley upgraded Madrigal Pharmaceuticals (MDGL) to Buy from Neutral with a price target of $422, up from $236. See what stocks are receiving Strong Buy ratings from top-rated analysts.

Here's a breakdown of the key members of the Madrigal family featured in Disney's "Encanto," their special powers, and the ...

Mets manager Carlos Mendoza informed reporters, including Anthony DiComo of MLB.com, that infielder Nick Madrigal will require surgery on his fractured left shoulder. The recovery from that ...

The answer is... yes! Peter took to Instagram earlier this week where he gave a glimpse inside of his career as the manager at SUR. In the photo, co-posted with the SUR Instagram account, Peter ...

The New York Mets have lost an important depth piece, Nick Madrigal, who is expected to miss the entire 2025 season. As manager Carlos Mendoza shared with reporters on Friday, the utility ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity, but GLP-1 competition from Novo and Lilly poses significant future challenges. Madrigal ...

New York Mets utility infielder Nick Madrigal will soon undergo shoulder surgery and likely miss the entirety of the upcoming 2025 season, manager Carlos Mendoza told reporters on Friday.

“Alma’s Way,” the Emmy-nominated animated series from Fred Rogers Productions, has been renewed for a third season at PBS Kids. The new season will feature 15 half-hour episodes, including a ...

With sales of $103 million in the fourth quarter and $180 million in its first nine months on the market, Madrigal Pharmaceuticals’ metabolic dysfunction-associated steatohepatitis (MASH ...